Argos Therapeutics (FRA:77AA) YoY EBITDA Growth : 79.19% (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Argos Therapeutics's YoY EBITDA Growth for the quarter that ended in Sep. 2018 was 79.19%.

Argos Therapeutics's EBITDA per Share for the three months ended in Sep. 2018 was €-0.35.

Argos Therapeutics YoY EBITDA Growth Historical Data

The historical data trend for Argos Therapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics YoY EBITDA Growth Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

YoY EBITDA Growth

Get a 7-Day Free Trial

71.39

-169.86

-33.68

53.77

64.01

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
YoY EBITDA Growth	Get a 7-Day Free Trial															69.42	96.97	98.23	86.37	79.19

Argos Therapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Argos Therapeutics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2017 is calculated as:

	YoY EBITDA Growth (A: Dec. 2017 )
=	(EBITDA per Share (A: Dec. 2017 )	-	EBITDA per Share (A: Dec. 2016 ))	/	\| EBITDA per Share (A: Dec. 2016 ) \|
=	(-10.727	-	-29.803)	/	\| -29.803 \|
=	64.01 %

Argos Therapeutics's YoY EBITDA Growth for the quarter that ended in Sep. 2018 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2018 )
=	(EBITDA per Share (Q: Sep. 2018 )	-	EBITDA per Share (Q: Sep. 2017 ))	/	\| EBITDA per Share (Q: Sep. 2017 )) \|
=	(-0.345	-	-1.658)	/	\| -1.658 \|
=	79.19 %

Argos Therapeutics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines